Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria
- University of Utah, United States
- UT Southwestern Medical Center, United States
- Harvard Medical School, United States
Abstract
Cells harbor two systems for fatty acid synthesis, one in the cytoplasm (catalyzed by fatty acid synthase, FASN) and one in the mitochondria (mtFAS). In contrast to FASN, mtFAS is poorly characterized, especially in higher eukaryotes, with the major product(s), metabolic roles, and cellular function(s) being essentially unknown. Here we show that hypomorphic mtFAS mutant mouse skeletal myoblast cell lines display a severe loss of electron transport chain (ETC) complexes and exhibit compensatory metabolic activities including reductive carboxylation. This effect on ETC complexes appears to be independent of protein lipoylation, the best characterized function of mtFAS, as mutants lacking lipoylation have an intact ETC. Finally, mtFAS impairment blocks the differentiation of skeletal myoblasts in vitro. Together, these data suggest that ETC activity in mammals is profoundly controlled by mtFAS function, thereby connecting anabolic fatty acid synthesis with the oxidation of carbon fuels.
Data availability
The data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019) partner repository. The code used to process these data is available at Github https://github.com/j-berg/nowinski_2020.Sequencing data have been deposited at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE148617
-
Mitochondrial fatty acid synthesis coordinates mitochondrial oxidative metabolismNCBI Gene Expression Omnibus, GSE148617.
Article and author information
Author details
Funding
National Institute of General Medical Sciences (GM115174)
- Jared Rutter
National Cancer Institute (R35CA22044901)
- Ralph J DeBerardinis
The Once Upon a Time Foundation
- Ralph J DeBerardinis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD096786)
- Ashley Solmonson
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107397)
- Katsuhiko Funai
National Institute of Diabetes and Digestive and Kidney Diseases (R21AG063077)
- Katsuhiko Funai
Office of the Director (S10OD016232)
- James E Cox
Office of the Director (S10OD021505)
- James E Cox
National Institute of Diabetes and Digestive and Kidney Diseases (U54DK110858)
- James E Cox
National Institute of General Medical Sciences (R01GM132129)
- Joao A Paulo
National Institute of General Medical Sciences (GM97645)
- Steven P Gygi
National Institute of General Medical Sciences (GM115129)
- Jared Rutter
National Institute of General Medical Sciences (GM110755)
- Dennis R Winge
The Nora Eccles Treadwell Foundation
- Jared Rutter
Howard Hughes Medical Institute (Investigator)
- Jared Rutter
United Mitochondrial Disease Foundation (PF-15-046)
- Sara M Nowinski
American Cancer Society (PF-18-106-01)
- Sara M Nowinski
National Heart, Lung, and Blood Institute (T32HL007576)
- Sara M Nowinski
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK11096601)
- Jordan A Berg
Howard Hughes Medical Institute (Investigator)
- Ralph J DeBerardinis
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Nowinski et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 11,955
- views
-
- 1,525
- downloads
-
- 80
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria
eLife 9:e58041.
https://doi.org/10.7554/eLife.58041
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Riboswitches represent a class of non-coding RNA that possess the unique ability to specifically bind ligands and, in response, regulate gene expression. A recent report unveiled a type of riboswitch, known as the guanidine-IV riboswitch, which responds to guanidine levels to regulate downstream genetic transcription. However, the precise molecular mechanism through which the riboswitch senses its target ligand and undergoes conformational changes remain elusive. This gap in understanding has impeded the potential applications of this riboswitch. To bridge this knowledge gap, our study investigated the conformational dynamics of the guanidine-IV riboswitch RNA upon ligand binding. We employed single-molecule fluorescence resonance energy transfer (smFRET) to dissect the behaviors of the aptamer, terminator, and full-length riboswitch. Our findings indicated that the aptamer portion exhibited higher sensitivity to guanidine compared to the terminator and full-length constructs. Additionally, we utilized Position-specific Labelling of RNA (PLOR) combined with smFRET to observe, at the single-nucleotide and single-molecule level, the structural transitions experienced by the guanidine-IV riboswitch during transcription. Notably, we discovered that the influence of guanidine on the riboswitch RNA’s conformations was significantly reduced after the transcription of 88 nucleotides. Furthermore, we proposed a folding model for the guanidine-IV riboswitch in the absence and presence of guanidine, thereby providing insights into its ligand-response mechanism.
-
- Biochemistry and Chemical Biology
The biosynthesis of cyclic 3′,5′-adenosine monophosphate (cAMP) by mammalian membrane-bound adenylyl cyclases (mACs) is predominantly regulated by G-protein-coupled receptors (GPCRs). Up to now the two hexahelical transmembrane domains of mACs were considered to fix the enzyme to membranes. Here, we show that the transmembrane domains serve in addition as signal receptors and transmitters of lipid signals that control Gsα-stimulated mAC activities. We identify aliphatic fatty acids and anandamide as receptor ligands of mAC isoforms 1–7 and 9. The ligands enhance (mAC isoforms 2, 3, 7, and 9) or attenuate (isoforms 1, 4, 5, and 6) Gsα-stimulated mAC activities in vitro and in vivo. Substitution of the stimulatory membrane receptor of mAC3 by the inhibitory receptor of mAC5 results in a ligand inhibited mAC5–mAC3 chimera. Thus, we discovered a new class of membrane receptors in which two signaling modalities are at a crossing, direct tonic lipid and indirect phasic GPCR–Gsα signaling regulating the biosynthesis of cAMP.
